OBJECTIVE: Acute respiratory distress syndrome/acute lung injury is a serious complication of burn patients with concomitant smoke inhalation injury. Nitric oxide has been shown to play a major role in pulmonary dysfunction from thermal damage. In this study, we have tested the hypothesis that inhibition of neuronal nitric oxide synthase could ameliorate the severity of acute lung injury using our well-established ovine model of cutaneous burn and smoke inhalation. DESIGN: Prospective, randomized, controlled, experimental animals study. SETTING: Investigational intensive care unit at university hospital. SUBJECTS: Adult female sheep. INTERVENTIONS: Female sheep (n = 16) were surgically prepared for the study. Seven days after surgery, all sheep were randomly allocated into three study groups: sham (noninjured, nontreated, n = 6); control (injured, treated with saline, n = 6); and neuronal nitric oxide synthase (injured, treated with specific neuronal nitric oxide synthase inhibitor, ZK 234238 (n = 4). Control and neuronal nitric oxide synthase groups were given a cutaneous burn (40% of total body surface, third degree) and insufflated with cotton smoke (48 breaths, <40 degrees C) under halothane anesthesia. Animals in sham group received fake injury also under halothane anesthesia. After injury or fake injury procedure, all sheep were placed on ventilators and resuscitated with lactated Ringer's solution. Neuronal nitric oxide synthase group was administered with continuous infusion of ZK 234238 started 1 hr postinjury with a dose of 100 microg/kg/hr. Sham and control groups received same amount of saline. MEASUREMENTS AND MAIN RESULTS: Cardiopulmonary hemodynamics monitored during the 24-hr experimental time period was stable in the sham group. Control sheep developed multiple signs of acute lung injury. This pathophysiology included decreased pulmonary gas exchange and lung compliance, increased pulmonary edema, and inflammatory indices, such as interleukin-8. Treatment of injured sheep with neuronal nitric oxide synthase inhibitor attenuated all the observed pulmonary pathophysiology. CONCLUSIONS: The results provide definitive evidence that inhibition of neuronal nitric oxide synthase-derived excessive nitric oxide may be a novel and beneficial treatment strategy for pulmonary pathology in burn victims with smoke inhalation injury.
OBJECTIVE: Acute respiratory distress syndrome/acute lung injury is a serious complication of burn patients with concomitant smoke inhalation injury. Nitric oxide has been shown to play a major role in pulmonary dysfunction from thermal damage. In this study, we have tested the hypothesis that inhibition of neuronal nitric oxide synthase could ameliorate the severity of acute lung injury using our well-established ovine model of cutaneous burn and smoke inhalation. DESIGN: Prospective, randomized, controlled, experimental animals study. SETTING: Investigational intensive care unit at university hospital. SUBJECTS: Adult female sheep. INTERVENTIONS: Female sheep (n = 16) were surgically prepared for the study. Seven days after surgery, all sheep were randomly allocated into three study groups: sham (noninjured, nontreated, n = 6); control (injured, treated with saline, n = 6); and neuronal nitric oxide synthase (injured, treated with specific neuronal nitric oxide synthase inhibitor, ZK 234238 (n = 4). Control and neuronal nitric oxide synthase groups were given a cutaneous burn (40% of total body surface, third degree) and insufflated with cotton smoke (48 breaths, <40 degrees C) under halothane anesthesia. Animals in sham group received fake injury also under halothane anesthesia. After injury or fake injury procedure, all sheep were placed on ventilators and resuscitated with lactated Ringer's solution. Neuronal nitric oxide synthase group was administered with continuous infusion of ZK 234238 started 1 hr postinjury with a dose of 100 microg/kg/hr. Sham and control groups received same amount of saline. MEASUREMENTS AND MAIN RESULTS: Cardiopulmonary hemodynamics monitored during the 24-hr experimental time period was stable in the sham group. Control sheep developed multiple signs of acute lung injury. This pathophysiology included decreased pulmonary gas exchange and lung compliance, increased pulmonary edema, and inflammatory indices, such as interleukin-8. Treatment of injured sheep with neuronal nitric oxide synthase inhibitor attenuated all the observed pulmonary pathophysiology. CONCLUSIONS: The results provide definitive evidence that inhibition of neuronal nitric oxide synthase-derived excessive nitric oxide may be a novel and beneficial treatment strategy for pulmonary pathology in burn victims with smoke inhalation injury.
Authors: Katsumi Shimoda; Kazunori Murakami; Perenlei Enkhbaatar; Lillian D Traber; Robert A Cox; Hal K Hawkins; Frank C Schmalstieg; Katalin Komjati; Jon G Mabley; Csaba Szabo; Andrew L Salzman; Daniel L Traber Journal: Am J Physiol Lung Cell Mol Physiol Date: 2003-03-07 Impact factor: 5.464
Authors: K Soejima; L D Traber; F C Schmalstieg; H Hawkins; J M Jodoin; C Szabo; E Szabo; L Virag; A Salzman; D L Traber; L Varig Journal: Am J Respir Crit Care Med Date: 2001-03 Impact factor: 21.405
Authors: Perenlei Enkhbaatar; Kazunori Murakami; Katsumi Shimoda; Akio Mizutani; Lillian Traber; Gary B Phillips; John F Parkinson; Robert Cox; Hal Hawkins; David Herndon; Daniel Traber Journal: Am J Respir Crit Care Med Date: 2003-04-01 Impact factor: 21.405
Authors: Perenlei Enkhbaatar; Kazunori Murakami; Katsumi Shimoda; Akio Mizutani; Roy McGuire; Frank Schmalstieg; Robert Cox; Hal Hawkins; Jeffery Jodoin; Steve Lee; Lillian Traber; David Herndon; Daniel Traber Journal: Am J Physiol Regul Integr Comp Physiol Date: 2003-05-22 Impact factor: 3.619
Authors: Linda E Sousse; Collette C Jonkam; Daniel L Traber; Hal K Hawkins; Sebastian W Rehberg; Lillian D Traber; David N Herndon; Perenlei Enkhbaatar Journal: Shock Date: 2011-11 Impact factor: 3.454
Authors: Yusuke Yamamoto; Linda E Sousse; Perenlei Enkhbaatar; Edward R Kraft; Donald J Deyo; Charlotte L Wright; Alan Taylor; Maret G Traber; Robert A Cox; Hal K Hawkins; Sebastian W Rehberg; Lillian D Traber; David N Herndon; Daniel L Traber Journal: Shock Date: 2012-12 Impact factor: 3.454
Authors: Perenlei Enkhbaatar; Jianpu Wang; Fiona Saunders; Matthias Lange; Atsumori Hamahata; Sebastian Rehberg; John F Parkinson; Lillian D Traber; David N Herndon; Daniel L Traber Journal: Burns Date: 2011-02-18 Impact factor: 2.744
Authors: Sebastian Rehberg; Yusuke Yamamoto; Linda E Sousse; Collette Jonkam; Robert A Cox; Donald S Prough; Perenlei Enkhbaatar Journal: J Trauma Acute Care Surg Date: 2014-01 Impact factor: 3.313
Authors: Sebastian Rehberg; Yusuke Yamamoto; Linda Sousse; Eva Bartha; Collette Jonkam; Anthony K Hasselbach; Lillian D Traber; Robert A Cox; Martin Westphal; Perenlei Enkhbaatar; Daniel L Traber Journal: Am J Physiol Heart Circ Physiol Date: 2012-09-07 Impact factor: 4.733
Authors: Satoshi Fukuda; Yosuke Niimi; Clark R Andersen; Ennert R Manyeza; Jose D Rojas; Donald S Prough; Perenlei Enkhbaatar Journal: Biochem Biophys Res Commun Date: 2020-03-18 Impact factor: 3.575
Authors: Sebastian Rehberg; Yusuke Yamamoto; Linda E Sousse; Collette Jonkam; Yong Zhu; Lillian D Traber; Robert A Cox; Donald S Prough; Daniel L Traber; Perenlei Enkhbaatar Journal: Crit Care Med Date: 2013-12 Impact factor: 7.598
Authors: Evgeny V Suborov; Alexey A Smetkin; Timofey V Kondratiev; Andrey Y Valkov; Vsevolod V Kuzkov; Mikhail Y Kirov; Lars J Bjertnaes Journal: BMC Anesthesiol Date: 2012-06-21 Impact factor: 2.217
Authors: Sebastian Rehberg; Yusuke Yamamoto; Eva Bartha; Linda E Sousse; Collette Jonkam; Yong Zhu; Lillian D Traber; Robert A Cox; Daniel L Traber; Perenlei Enkhbaatar Journal: Crit Care Date: 2013-05-11 Impact factor: 9.097